Boundless Bio (BOLD) Other Working Capital Changes (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Other Working Capital Changes of -$747000.0 for Q1 2026, down 179.3% year-over-year from $942000.0 in Q1 2025, and down 4.48% quarter-over-quarter from -$715000.0 in Q4 2025.
Boundless Bio (BOLD) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Other Working Capital Changes for 4 consecutive years, with -$747000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 179.3% year-over-year to -$747000.0; the TTM figure through Mar 2026 stood at -$193000.0 (up 64.06% YoY), while the FY2025 annual figure was $1.5 million, up 169.55% from the prior year.
- Other Working Capital Changes retreated to -$747000.0 in Q1 2026 per BOLD's latest filing, from -$715000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q2 2024 and bottomed at -$997000.0 in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$28076.9 across 4 years, with a median of -$87000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 240.18% in 2025 and fell as far as 828.57% in 2025.
- Boundless Bio's Other Working Capital Changes stood at -$816000.0 in 2023, then soared by 90.56% to -$77000.0 in 2024, then sank by 828.57% to -$715000.0 in 2025, then fell by 4.48% to -$747000.0 in 2026.
- Business Quant data shows BOLD's Other Working Capital Changes at -$747000.0 in Q1 2026, -$715000.0 in Q4 2025, and $333000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.69 Mn |
| Jun 30, 2026 | -11.69 Mn |
| Jun 30, 2026 | -11.69 Mn |
| Mar 31, 2026 | -747,000.00 |
| Mar 31, 2026 | -747,000.00 |
| Mar 31, 2026 | -747,000.00 |
| Dec 31, 2025 | -715,000.00 |
| Dec 31, 2025 | -715,000.00 |
| Dec 31, 2025 | -715,000.00 |
| Sep 30, 2025 | 333,000.00 |
| Sep 30, 2025 | 333,000.00 |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 936,000.00 |
| Jun 30, 2025 | 936,000.00 |
| Jun 30, 2025 | 936,000.00 |
| Mar 31, 2025 | 942,000.00 |
| Mar 31, 2025 | 942,000.00 |
| Mar 31, 2025 | 942,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Dec 31, 2024 | -77,000.00 |